Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-28

FDA Approved: TLANDO — Original Application (Verity Pharmaceuticals Inc.)

View source ↗

Summary

TLANDO (testosterone undecanoate) received FDA approval as a new oral testosterone replacement therapy for adult males with hypogonadism. It provides testostero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TLANDO (Testosterone undecanoate)

Snippet

ORIG AP for TLANDO (TESTOSTERONE UNDECANOATE)